Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4530227

Cc1cccc(C)c1C1CCN(Cc2c(C(=O)N3CCN(CC4CCCCC4)CC3)[nH]c3ccccc23)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 3/20 0.46
MCL1 Q07820 5/20 0.41
KDM4E B2RXH2 2/20 0.41
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
MAPT P10636 1/20 0.41
HTT P42858 1/20 0.41
KMT2A Q03164 1/20 0.41
OPRM1 P35372 1/20 0.40
OPRD1 P41143 1/20 0.40
OPRK1 P41145 1/20 0.40
OPRL1 P41146 1/20 0.40
TPSAB1 Q15661 3/20 0.40
SLC2A1 P11166 1/20 0.39
TNKS O95271 1/20 0.39
BCHE P06276 1/20 0.38
ACHE P22303 1/20 0.38
TLR9 Q9NR96 1/20 0.37
TLR8 Q9NR97 1/20 0.37
TLR7 Q9NYK1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4524065 0.90 ALDH1A1 (0.43) CNR1MCL1KDM4EMEN1ALDH1A1
Trifluoroacetic Acid SCHEMBL4521622 0.90 ALDH1A1 (0.43) CNR1MCL1KDM4EMEN1ALDH1A1
Trifluoroacetic Acid SCHEMBL4529169 0.90 KDM4E (0.41) CNR1MCL1KDM4EMEN1ALDH1A1
Trifluoroacetic Acid SCHEMBL4523754 0.90 CNR1 (0.43) CNR1MCL1KDM4EMEN1ALDH1A1
Trifluoroacetic Acid SCHEMBL4515923 0.89 MCL1 (0.44) MCL1KDM4EMEN1ALDH1A1MAPT
Trifluoroacetic Acid SCHEMBL4514539 0.89 ALDH1A1 (0.43) MCL1KDM4EMEN1ALDH1A1MAPT
Trifluoroacetic Acid SCHEMBL4515642 0.88 KDM4E (0.43) MCL1KDM4EMEN1ALDH1A1MAPT
Trifluoroacetic Acid SCHEMBL4520540 0.88 TPSAB1 (0.41) MCL1KDM4EMEN1ALDH1A1MAPT
Trifluoroacetic Acid SCHEMBL4527558 0.88 HRH4 (0.42) MCL1KDM4EMEN1ALDH1A1MAPT
Trifluoroacetic Acid SCHEMBL4521028 0.87 HTR2A (0.47) MCL1KDM4EMEN1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090275555-A1 Substituted indole ligands for the ORL-1 receptor BRANE DISCOVERY S.R.L. (IT) 2009-11-05 US claimed
EP-1841755-A1 SUBSTITUTED INDOLE LIGANDS FOR THE ORL-1 RECEPTOR BRANE DISCOVERY S.R.L. (IT) 2007-10-10 EP claimed
WO-2006070001-A1 SUBSTITUTED INDOLE LIGANDS FOR THE ORL-1 RECEPTOR BRANE DISCOVERY S.R.L. (IT) 2006-07-06 WO claimed
US-20090275555-A1 Substituted indole ligands for the ORL-1 receptor BRANE DISCOVERY S.R.L. (IT) 2009-11-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090275555-A1 Substituted indole ligands for the ORL-1 receptor OGFRL1, OPRL1, ORMDL3 CNR1 18/4885MCL1 1303/4885KDM4E 4525/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.